Dr. Reddy's Laboratories
- Advice
- Hold
Start SIP in Dr. Reddy's Laboratories
Start SIPDr. Reddy's Laboratories Performance
Day Range
- Low 6,001
- High 6,065
52 Week Range
- Low 4,384
- High 6,506
- Open Price6,050
- Previous Close6,016
- Volume134255
Dr. Reddy's Laboratories F&O
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 4,103 | 4,839 | 5,437 | 4,249 |
Operating Expenses Qtr Cr | 3,447 | 3,210 | 3,210 | 3,489 |
Operating Profit Qtr Cr | 656 | 1,629 | 2,228 | 1,061 |
Depreciation Qtr Cr | 246 | 246 | 237 | 237 |
Interest Qtr Cr | 6 | 6 | 5 | 3 |
Tax Qtr Cr | 157 | 408 | 580 | 264 |
Net Profit Qtr Cr | 475 | 1,193 | 1,639 | 672 |
Dr. Reddy's Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹6,107.92
- 50 Day
- ₹6,123.27
- 100 Day
- ₹6,000.81
- 200 Day
- ₹5,727.37
- 20 Day
- ₹6,113.36
- 50 Day
- ₹6,234.19
- 100 Day
- ₹5,995.79
- 200 Day
- ₹5,762.80
Dr. Reddy's Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | 6,068.90 |
Second Resistance | 6,121.70 |
Third Resistance | 6,179.40 |
RSI | 41.88 |
MFI | 39.82 |
MACD Single Line | -41.26 |
MACD | -60.04 |
Support | |
---|---|
First Resistance | 5,958.40 |
Second Resistance | 5,900.70 |
Third Resistance | 5,847.90 |
Dr. Reddy's Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 340,893 | 20,255,862 | 59.42 |
Week | 434,458 | 25,215,957 | 58.04 |
1 Month | 356,102 | 18,617,037 | 52.28 |
6 Month | 427,838 | 22,388,742 | 52.33 |
Dr. Reddy's Laboratories Result Highlights
Dr. Reddy's Laboratories Synopsis
NSE-Medical-Diversified
Dr. Reddy's Labs is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 16962.50 Cr. and Equity Capital is Rs. 83.30 Cr. for the Year ended 31/03/2023. Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507.Market Cap | 100,497 |
Sales | 18,933 |
Shares in Float | 12.18 |
No of funds | 968 |
Yield | 0.67 |
Book Value | 4.9 |
U/D Vol ratio | 0.9 |
LTDebt / Equity | |
Alpha | 0.04 |
Beta | 0.43 |
Dr. Reddy's Laboratories
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 26.65% | 26.65% | 26.66% | 26.69% |
Mutual Funds | 7.96% | 8.22% | 8.61% | 9.31% |
Insurance Companies | 7.72% | 7.94% | 10.14% | 12.56% |
Foreign Portfolio Investors | 29.13% | 28.62% | 28.19% | 26.99% |
Financial Institutions/ Banks | 0.07% | 0.05% | 0.01% | |
Individual Investors | 8.25% | 8.44% | 7.91% | 7.52% |
Others | 20.22% | 20.08% | 18.49% | 16.92% |
Dr. Reddy's Laboratories Management
Name | Designation |
---|---|
Mr. K Satish Reddy | Chairman |
Mr. G V Prasad | Co-Chairman & Manag. Director |
Ms. Kalpana Morparia | Independent Director |
Mr. Leo Puri | Independent Director |
Dr. Claudio Albrecht | Independent Director |
Ms. Shikha Sharma | Independent Director |
Ms. Penny Wan | Independent Director |
Mr. Sridar Iyengar | Independent Director |
Mr. Arun Madhavan Kumar | Independent Director |
Dr. K P Krishnan | Independent Director |
Dr. Reddy's Laboratories Forecast
Price Estimates
Dr. Reddy's Laboratories Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-07 | Audited Results & Final Dividend | |
2024-01-30 | Quarterly Results | |
2023-10-27 | Quarterly Results | |
2023-07-26 | Quarterly Results | |
2023-05-10 | Audited Results & Final Dividend |
About Dr. Reddy's Laboratories
Dr. Reddy's Laboratories FAQs
What is Share Price of Dr. Reddy's Laboratories ?
Dr. Reddy's Laboratories share price is ₹6,021 As on 23 April, 2024 | 12:08
What is the Market Cap of Dr. Reddy's Laboratories ?
The Market Cap of Dr. Reddy's Laboratories is ₹100439.1 Cr As on 23 April, 2024 | 12:08
What is the P/E ratio of Dr. Reddy's Laboratories ?
The P/E ratio of Dr. Reddy's Laboratories is 19.2 As on 23 April, 2024 | 12:08
What is the PB ratio of Dr. Reddy's Laboratories ?
The PB ratio of Dr. Reddy's Laboratories is 4.3 As on 23 April, 2024 | 12:08
What is Dr Reddys Laboratories's stock price CAGR?
Dr Reddys Laboratories stock price CAGR for 10 Years stands at 12%, 5 Years at 8%, 3 Years at 20%, and 1 Year at -2%.
What is the ROE of Dr Reddys Laboratories?
The ROE of Dr Reddys Laboratories is 11%.
Is Dr Reddys Laboratories a good investment?
Dr Reddy's Laboratories has an operating revenue of Rs. 20,442.10 Cr. on a trailing 12-month basis. Annual revenue growth of 7% is good, Pre-tax margin of 15% is great. As per analysts rating in the last 6 months, the recommendation is to HOLD Dr Reddys Laboratories.
Who is the CEO of Dr Reddys Laboratories
Erez Israeli is the Chief Executive Officer (CEO) at Dr Reddy's Laboratories since 1 Aug 2019.
What is the Profit before tax of Dr. Reddys Laboratories Ltd stock?
Profit before tax of Dr. Reddys Laboratories Ltd stock for the quarter ended March 2022 is Rs 567 crores.
Q) How to buy Dr. Reddys Laboratories Ltd shares?
Ans - You can easily buy the shares of Dr. Reddys Laboratories Ltd, by registering at 5Paisa and by setting up a Demat Account in your name.
Q) What is the 52-week high and low price of shares of Dr Reddys Laboratories Ltd.
Ans – Dr Reddys Laboratories Ltd shares have a 52-week high of Rs 5,614.60 and a 52-week low of Rs 3,654.
Q) What is the Return of Equity on shares of Dr Reddys Laboratories Ltd for the past 1 year?
Ans – The Return on Equity on shares of Dr Reddys Laboratories Ltd is 11.8% for last year.
Q) What is the face value of a share of Dr Reddys Laboratories Ltd?
Ans – The face value of a share of Dr Reddys Laboratories Ltd. is INR 5 per share.